Advertisement

Topics

Intercept Pharma Announces Positive Results From The Phase II AESOP Trial Evaluating OCA For The Treatment Of Patients With Primary Sclerosing Cholangitis

20:00 EDT 30 Jul 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Intercept Pharma Announces Positive Results From The Phase II AESOP Trial Evaluating OCA For The Treatment Of Patients With Primary Sclerosing Cholangitis

NEXT ARTICLE

More From BioPortfolio on "Intercept Pharma Announces Positive Results From The Phase II AESOP Trial Evaluating OCA For The Treatment Of Patients With Primary Sclerosing Cholangitis"

Quick Search
Advertisement